PLoS ONE · 2011 · 49 citations · 34 references
MedicineOncologyPharmacologyCancer PharmacologyChemotherapyMolecular PharmacologyAnthracycline CardiotoxicityCancer Therapy-related CardiotoxicityCardiac PharmacotherapyCardiotoxicity ManagementOncology PharmacologyAnnexin V AssaysAnthracycline-induced CardiotoxicityCardioprotective TherapyChemotherapy-induced CardiomyopathyDoxorubicin CardiotoxicityMechanisms Of Cardiac InjuryNeuroprotective MechanismsSmall Heat Shock Proteins
BACKGROUND: Despite its effectiveness in the treatment of various cancers, the use of doxorubicin is limited by a potentially fatal cardiomyopathy. Prevention of this cardiotoxicity remains a critical issue in clinical oncology. We hypothesized that flavaglines, a family of natural compounds that display potent neuroprotective effects, may also alleviate doxorubicin-induced cardiotoxicity. METHODOLOGY/PRINCIPAL FINDINGS: Our in vitro data established that a pretreatment with flavaglines significantly increased viability of doxorubicin-injured H9c2 cardiomyocytes as demonstrated by annexin V, TUNEL and active caspase-3 assays. We demonstrated also that phosphorylation of the small heat shock protein Hsp27 is involved in the mechanism by which flavaglines display their cardioprotective effect. Furthermore, knocking-down Hsp27 in H9c2 cardiomyocytes completely reversed this cardioprotection. Administration of our lead compound (FL3) to mice attenuated cardiomyocyte apoptosis and cardiac fibrosis, as reflected by a 50% decrease of mortality. CONCLUSIONS/SIGNIFICANCE: These results suggest a prophylactic potential of flavaglines to prevent doxorubicin-induced cardiac toxicity.
34
Congestive heart failure in patients treated with doxorubicin
Sandra M. Swain, Fredrick S. Whaley, Michael S. Ewer · Cancer · 2003 · 2.3K citations · Full text
Medicine, Oncology, Pharmacology +15
Partha Mukhopadhyay, Mohanraj Rajesh, Sándor Bátkai et al. · American Journal of Physiology-Heart and Circulatory Physiology · 2009 · 379 citations · Full text
Medicine, Pharmacology, Toxicology +17